Brittney Griner Russia Detention: Cannabis Vape, 9-Year Sentence

February 17, 2022: Sheremetyevo Airport

WNBA All-Star and Phoenix Mercury center Brittney Griner was detained at Sheremetyevo International Airport in Moscow on February 17, 2022. Russian customs officials reported finding cannabis-vape cartridges in her luggage. Griner held a medical-cannabis prescription issued under Arizona state law. The detention occurred days before Russia's full-scale invasion of Ukraine; the case became inextricable from the geopolitical context that followed.

Why a WNBA Star Was in Russia in February

Griner was returning to play for UMMC Yekaterinburg, a Russian club where she earned a multi-million-dollar offseason contract — an order of magnitude above her WNBA salary. The wage asymmetry between the WNBA and overseas leagues has driven dozens of top WNBA players to compete in Russia, China, Turkey, and Israel during the WNBA offseason for years. The Griner case is now the most-cited example of why that economic structure carries non-financial risks.

The Nine-Year Sentence (August 4, 2022)

On August 4, 2022, a Russian court sentenced Griner to nine years in a penal colony on cannabis-related charges under the Russian Criminal Code. The sentence was at the upper end of the statutory range and was widely understood, in U.S. diplomatic framing, to reflect both the strict-liability character of Russian narcotics enforcement and the broader U.S.-Russia bilateral context. Griner was subsequently transferred to IK-2 in Mordovia.

December 8, 2022: The Bout Swap

On December 8, 2022, the United States announced Griner's release in a one-for-one prisoner swap for Viktor Bout, the Russian arms dealer convicted in U.S. federal court in 2011 and serving a 25-year sentence. The swap was negotiated by the U.S. State Department through the United Arab Emirates. Former U.S. Marine Paul Whelan, also detained in Russia, was not included in the deal — a point of public criticism the Biden administration addressed in its public statements that day.

The WNBA Implications: A New Travel-Risk Conversation

The Griner case reframed every WNBA-overseas conversation about cannabis-related travel risk. Three downstream effects are now part of women's professional sports labour discussion:

• The wage-asymmetry argument. The case sharpened WNBA-WNBPA collective-bargaining advocacy for higher base salaries and league-funded offseason alternatives that reduce the economic pressure to play abroad.
• The travel-risk advisory. WNBA player-services functions, the WNBPA, and U.S. State Department travel guidance now treat cannabis-related contraband as a high-risk category for any athlete travelling to Russia, the UAE, much of Asia, and parts of the Caribbean — regardless of the athlete's home-state prescription status.
• The CBD-product travel-risk reframe. Because hemp-derived CBD products can contain trace THC under U.S. labeling standards (Bonn-Miller et al., JAMA, 2017 — 21% of online CBD products contained THC; 69% mislabelled overall), athletes are now routinely advised not to carry any hemp or CBD product internationally without verifying recipient-country law, even if NSF Certified for Sport.

Strict Liability, International Edition

Anti-doping strict liability holds athletes responsible for everything in their bodies, regardless of intent (see TUEs & Strict Liability). The Griner case extends the principle from the testing room to the customs counter: athletes are responsible for everything in their luggage, regardless of medical status in the home country. The U.S. medical-cannabis prescription was a public-opinion fact, not a legal defense under Russian law. The same logic applies in materially every non-North American jurisdiction: the recipient country's narcotics statute governs — not the home-state prescription, not the WNBA medical exemption, not the hemp-derived label.

Aftermath: Return to the WNBA, Continued Advocacy

Griner returned to the Phoenix Mercury and resumed her WNBA career in 2023. Her public advocacy for incarcerated U.S. nationals abroad and for WNBA labour reform continues. The case sits in the master cases ledger as a category-defining instance: not a doping case, not a league-discipline case, but a reminder that for elite athletes who travel internationally, cannabis-related risk reaches well beyond the testing-and-suspension framework most CBA and anti-doping pages describe.